Related references
Note: Only part of the references are listed.TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma
David W. Scott et al.
BLOOD (2012)
Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11
J. E. Noll et al.
ONCOGENE (2012)
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
Andrew L. Feldman et al.
BLOOD (2011)
Primary Cutaneous CD30+ Anaplastic Large-Cell Lymphomas Show a Heterogeneous Genomic Profile: An Oligonucleotide ArrayCGH Approach
Julia Ma Sanchez-Schmidt et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
ΔNp63 Regulates Stem Cell Dynamics in the Mammalian Olfactory Epithelium
Adam Packard et al.
JOURNAL OF NEUROSCIENCE (2011)
Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies
David A. Wada et al.
MODERN PATHOLOGY (2011)
The role of P63 in cancer, stem cells and cancer stem cells
Marta Nekulova et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2011)
Dominant negative (ΔN) p63α induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways
Heiko M. Mundt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time
David E. Gerber et al.
CANCER CELL (2010)
Synergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly(ADP-Ribose) Polymerase Inhibition, Gemcitabine, and Cisplatin
Kedar Hastak et al.
CANCER RESEARCH (2010)
Development and validation of a comprehensive mutation and deletion detection assay for SDHB, SDHC, and SDHD
Dragana Milosevic et al.
CLINICAL BIOCHEMISTRY (2010)
Identification of ΔNp63α Protein Interactions by Mass Spectrometry
Angela Amoresana et al.
JOURNAL OF PROTEOME RESEARCH (2010)
CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma
Elodie Laharanne et al.
MODERN PATHOLOGY (2010)
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
Xiaohua Su et al.
NATURE (2010)
The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target
K-John J. Cheung et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Overexpression of ΔNp63 in a Human Nasopharyngeal Carcinoma Cell Line Downregulates CKIs and Enhances Cell Proliferation
Chi-Tai Chiang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
A. L. Feldman et al.
LEUKEMIA (2009)
TAp63 induces senescence and suppresses tumorigenesis in vivo
Xuecui Guo et al.
NATURE CELL BIOLOGY (2009)
Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization
Andrew L. Feldman et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified:: report from the International Peripheral T-Cell Lymphoma Project
Kerry J. Savage et al.
BLOOD (2008)
Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation
Luciano J. Costa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Therapeutic prospects for p73 and p63: Rising from the shadow of p53
Anna Vilgelm et al.
DRUG RESISTANCE UPDATES (2008)
Identification of ANKRD11 as a p53 coactivator
Paul M. Neilsen et al.
JOURNAL OF CELL SCIENCE (2008)
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas
A. L. Feldman et al.
LEUKEMIA (2008)
Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma
Matthew W. Jenner et al.
BLOOD (2007)
The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers
Chee-Onn Leong et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
p63 transcriptional regulation of epithelial integrity and cancer
Barry Trink et al.
CELL CYCLE (2007)
Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma
Maurice Phillip DeYoung et al.
CANCER RESEARCH (2006)
p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis
JW Rocco et al.
CANCER CELL (2006)
WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53
NS Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma
GZ Rassidakis et al.
LEUKEMIA (2005)
Expression of p63 in diffuse large B-cell lymphoma
CV Hedvat et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2005)
INK4a/ARF:: A multifunctional tumor suppressor locus
NE Sharpless
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification
KJ Savage et al.
ANNALS OF ONCOLOGY (2004)
p63α mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome
A Fomenkov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genes
JA Powell et al.
GENOMICS (2002)
Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations
B Petit et al.
HUMAN PATHOLOGY (2001)
P63 and p73: P53 mimics, menaces and more
A Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2000)
High level expression of ΔN-p63:: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?
T Crook et al.
ONCOGENE (2000)
Share Paper
